Pre-Open Stock Movers:

Tyme Technologies, Inc. (NASDAQ: TYME) 60% HIGHER; announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Company’s metabolomic technology platform. The patent, U.S. Patent No. 10,905,698, is directed to methods for treating COVID-19.

Vaxart, Inc., (NASDAQ: VXRT) 53.2% LOWR; announced preliminary data from its Phase 1 study of VXA-CoV2-1 showing that its oral COVID-19 tablet vaccine candidate was generally well-tolerated, and immunogenic as measured by multiple markers of immune response to SARS-CoV-2 antigens.

GW Pharmaceuticals plc (Nasdaq: GWPH) 48.4% HIGHER; Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second quarter of 2021.

Koss Corporation (NASDAQ: KOSS) 37.5% HIGHER; meme stocks gains after sell-off on Tuesday

Clene, Inc. (NASDAQ: CLNN) 26.4% HIGHER; Roth Capital initiates coverage with a Buy rating and a price target of $24.00.

GameStop Corp. (NYSE: GME) 20% HIGHER; today announced that it has appointed Matt Francis to the newly-created role of Chief Technology Officer. Mr. Francis has a start date of February 15, 2021. Mr. Francis brings more than two decades of experience in e-commerce and consumer technology to GameStop. Most recently, he was an Engineering Leader at Amazon Web Services. He previously held senior-level technology roles at companies such as QVC and Zulily. At GameStop, Mr. Francis will be responsible for overseeing e-commerce and technology functions.

Voyager Therapeutics, Inc. (Nasdaq: VYGR) 13% LOWER; announced that Neurocrine Biosciences, Inc. (Nasdaq: NBIX) provided notice of termination of the Parkinsons disease portion of the collaboration agreement, effective August 2, 2021. The Friedreichs ataxia program and two discovery programs that are also part of the agreement are not impacted and remain under active collaboration.

Tenable Holdings, Inc. (NASDAQ: TENB) 10.2% LOWER; reported Q4 EPS of $0.13, $0.07 better than the analyst estimate of $0.06. Revenue for the quarter came in at $118.1 million versus the consensus estimate of $114.85 million.

Investors Bancorp Inc. (NASD: ISBC) 10% HIGHER; will replace BioTelemetry Inc. (NASD: BEAT) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 10. Koninklijke Philips N.V. (NYSE: PHG) is acquiring BioTelemetry in a deal expected to be completed soon pending final conditions.

Tilray, Inc. (NASDAQ: TLRY) 8.4% HIGHER; adds to intra-day gains on hopes for U.S. federal legilization of pot.

Accuray (NASDAQ: ARAY) 8.3% HIGHER; Director, Joseph Whitters, bought 20,000 shares on 02/01 at $5.02.

PEDEVCO Corp. (NYSE: PED) 8% LOWER; today announced its intention to offer its shares of common stock ("Shares") in a firm commitment underwritten public offering.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) 7.9% HIGHER; reported Q4 EPS of $22.30, $6.31 better than the analyst estimate of $15.99. Revenue for the quarter came in at $56.9 billion versus the consensus estimate of $53.15 billion.

Meritor (NYSE: MTOR) 7.7% HIGHER; reported Q1 EPS of $0.60, $0.29 better than the analyst estimate of $0.31. Revenue for the quarter came in at $889 million versus the consensus estimate of $797.55 million. Meritor sees FY2021 EPS of $2.25-$2.50, versus the consensus of $2.00. Meritor sees FY2021 revenue of $3.65-3.8 million, versus the consensus of $3.46 million.

Amcor plc (NYSE: AMCR) 7% HIGHER; reported Q2 GAAP EPS of $0.12, which may not compare to the analyst estimate of $0.17. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $3.08 billion.

Spotify (NYSE: SPOT) 7% LOWER; reported Q4 EPS of (EUR0.66), versus (EUR1.14) reported last year. Revenue for the quarter came in at EUR2.17 billion, versus EUR1.86 billion reported last year. Spotify sees Q1 2021 revenue of EUR1.99-2.19 billion. Spotify sees FY2021 revenue of EUR9.01-9.41 billion.

Opendoor Technologies Inc. (Nasdaq: OPEN) 5.9% LOWER; announced that it has commenced an underwritten public offering of 24,000,000 shares of its common stock

Match Group (NASDAQ: MTCH) 5.4% LOWER; reported Q4 EPS of $0.48, $0.01 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $651.41 million versus the consensus estimate of $648.76 million. Match Group sees FY2021 revenue of $2.75-2.85 billion, versus the consensus of $2.39 billion.

United States Steel Corporation (NYSE: X) 4.9% LOWER; announced today that it has commenced an underwritten public offering of 40,000,000 shares of common stock.

Electronic Arts (NASDAQ: EA) 4.6% LOWER; reported Q3 EPS of $0.72, $2.24 worse than the analyst estimate of $2.96. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $2.39 billion.

Viavi Solutions (NASDAQ: VIAV) 4% HIGHER; reported Q2 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $313.7 million versus the consensus estimate of $290.49 million.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 3.7% LOWER; Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second quarter of 2021.

Albemarle Corporation (NYSE: ALB) 1.9% LOWER; announced that it has commenced an underwritten public offering of $1,300,000,000 of shares of its common stock